Also known as: Ladder Therapeutics (LTX)
Genetic Medicine with Small Molecules
Company is active
Event Year: 2022
Company is active
Event Year: 2022
Serna Bio is dedicated to the development of innovative small molecule therapeutics designed to modulate RNA function. This approach aims to unlock new treatment avenues for diseases that have proven resistant to other therapeutic modalities, addressing previously intractable biological targets. By precisely targeting RNA, Serna Bio seeks to create effective and targeted therapies for a range of challenging diseases.
Serna Bio is dedicated to the development of innovative small molecule therapeutics designed to modulate RNA function. This approach aims to unlock new treatment avenues for diseases that have proven resistant to other therapeutic modalities, addressing previously intractable biological targets. By precisely targeting RNA, Serna Bio seeks to create effective and targeted therapies for a range of challenging diseases.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2021
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2021
Healthcare
Healthcare
Healthcare -> Therapeutics
Healthcare -> Therapeutics
Team size: 5
Hiring: No
Team size: 5
Hiring: No
